{"id":"NCT01958021","sponsor":"Novartis Pharmaceuticals","briefTitle":"Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer","officialTitle":"A Randomized Double-blind, Placebo-controlled Study of LEE011 in Combination With Letrozole for the Treatment of Postmenopausal Women With Hormone Receptor Positive, HER2 Negative, Advanced Breast Cancer Who Received no Prior Therapy for Advanced Disease","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-12-17","primaryCompletion":"2016-01-29","completion":"2023-03-16","firstPosted":"2013-10-08","resultsPosted":"2017-05-12","lastUpdate":"2025-03-07"},"enrollment":668,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Advanced, Metastatic Breast Cancer"],"interventions":[{"type":"DRUG","name":"Ribociclib","otherNames":["LEE011"]},{"type":"DRUG","name":"Letrozole","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Ribociclib+ letrozole","type":"EXPERIMENTAL"},{"label":"Placebo + letrozole","type":"PLACEBO_COMPARATOR"}],"summary":"The primary purpose of this study was to assess the efficacy of ribociclib, as measured by progression free survival (PFS), in postmenopausal women with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) advanced breast cancer who received no prior treatment for advanced disease.","primaryOutcome":{"measure":"Progression Free Survival (PFS) by Investigator Assessment","timeFrame":"Up to 23 months","effectByArm":[{"arm":"Ribociclib + Letrozole","deltaMin":null,"sd":null},{"arm":"Placebo + Letrozole","deltaMin":14.7,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.00000329"}]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":221,"countries":["United States","Argentina","Australia","Austria","Belgium","Brazil","Canada","Czechia","Denmark","Finland","France","Germany","Hungary","Ireland","Israel","Italy","Lebanon","Netherlands","Norway","Russia","Singapore","South Africa","South Korea","Spain","Sweden","Taiwan","Thailand","Turkey (TÃ¼rkiye)","United Kingdom"]},"refs":{"pmids":["38107828","37673211","36861085","36800111","35263519","34158598","33769862","31305131","30340505","29718092","29404806","27717303"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":108,"n":334},"commonTop":["Nausea","Arthralgia","Fatigue","Neutropenia","Diarrhoea"]}}